top of page

Low Dose Naltrexone (LDN): An Innovative Treatment for Fibromyalgia, Chronic Pain, and Autoimmune Conditions

 

What Is Low-Dose Naltrexone?

Low Dose Naltrexone (LDN) is emerging as a powerful alternative treatment for individuals suffering from fibromyalgia, chronic pain, and a range of autoimmune disorders. Originally approved by the FDA in the 1980s for treating opioid addiction and alcohol dependence, Naltrexone is now being repurposed at low doses to help manage conditions characterized by inflammation, immune dysfunction, and chronic fatigue.

At standard doses (typically 50mg), Naltrexone works by blocking opioid receptors in the brain to reduce the euphoric effects of alcohol and narcotics. However, when used in much smaller amounts—commonly between 1.5mg and 4.5mg—the effects are completely different and therapeutic for a wider range of conditions.

The Origins of LDN: A Repurposed Drug With New Purpose

The concept of using low-dose Naltrexone for immune modulation began with Dr. Bernard Bihari, who discovered its potential benefits in treating AIDS-related inflammation in the 1980s. Since then, LDN has shown promise in treating:

  • Fibromyalgia

  • Chronic pain conditions

  • Multiple Sclerosis (MS)

  • Crohn’s disease

  • Chronic Fatigue Syndrome (CFS)

  • Lupus and other autoimmune diseases

How Does LDN Work?

LDN temporarily blocks opioid receptors for a few hours. In people who are not using opioids, this blocking action tricks the body into increasing endorphin production—our body’s natural painkillers. These elevated endorphin levels have been shown to help reduce pain, inflammation, and symptoms associated with immune dysfunction.

Additionally, LDN reduces the activity of microglia, immune cells in the central nervous system that contribute to pain signaling and inflammation. This may explain why LDN has been effective in lowering pain levels in fibromyalgia and other chronic pain syndromes.

LDN and Fibromyalgia: Natural Pain Relief with Fewer Side Effects

Patients with fibromyalgia often face a long road of trial-and-error with medications. Conventional treatments can come with unwanted side effects and limited relief. LDN offers a safer, low-risk alternative.

Clinical studies, such as those led by Dr. Jarred Younger, have shown that LDN can significantly reduce fibromyalgia symptoms, including:

  • Muscle pain and tenderness

  • Brain fog

  • Poor sleep quality

  • Chronic fatigue

Unlike traditional pharmaceuticals, LDN is well-tolerated, non-addictive, and does not suppress the immune system.

Is Low-Dose Naltrexone FDA Approved?

While Low Dose Naltrexone is not yet FDA-approved for fibromyalgia or autoimmune conditions, it is available via prescription and can be filled at most compounding pharmacies. Doctors prescribe it off-label, a common and legal medical practice, especially when supported by clinical evidence and patient outcomes.

The Benefits of LDN for Chronic Pain and Autoimmune Diseases

  • ✅ Boosts natural endorphins

  • ✅ Reduces chronic inflammation

  • ✅ Helps regulate immune system activity

  • ✅ Fewer side effects than traditional pain medications

  • ✅ Affordable and accessible through compounding pharmacies

Final Thoughts: Is LDN Right for You?

If you're suffering from chronic pain, fibromyalgia, or a persistent autoimmune condition, Low Dose Naltrexone may be a safe and effective treatment option. With ongoing research and a growing number of success stories, LDN is rapidly gaining recognition as a low-risk therapy with high potential.

References

  • Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies into Medical Practice. Substance Abuse and Mental Health Services Administration.

  • Younger J., Parkitny L., McLain D. The use of Low Dose Naltrexone as a novel anti-inflammatory treatment for chronic pain.

  • Toljan K., Vrooman B. Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization.

© 2021 by Carolina Forest Pharmacy

bottom of page